Clinical Utility of Pharmacogenetic Biomarkers in Cardiovascular Therapeutics: a Challenge for Clinical Implementation
Frank S Ong(Cedars-Sinai Medical Center), Kingshuk Das(University of California, Los Angeles), Jerome I. Rotter(Harbor–UCLA Medical Center), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Wayne W. Grody(University of California, Los Angeles), Joshua L. Deignan(University of California, Los Angeles), Jane Kuo(Cedars-Sinai Medical Center)
Cited by 31
Related Papers
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
|Nature Genetics|2007|1.8k
Genome-wide association study of blood pressure and hypertension
|Nature Genetics|2009|1.4k